Search

Hanumath G Kari

from Hatfield, PA
Get Report
Also known as:
Kari Prasad, Prasad H Kari
Phone and address:
1064 Hertford Dr, Hatfield, PA 19440
(215) 368-5316
Related to:
Kari Madhavi, 50U P Kari, 76Swathi S Kari, 35Rama D Kari, 67Kari U Prasad, 84Manjula Kari, 44
Connected to:
Archana Kari, 39Cathryn J Kari, 78Meaghan Kari, 34Pat Kari, 71Ray A Kari, 61Ron D Kari, 58Sina Kari, 44Victoria E Kari, 34Disha A Karia, 34Pratik N Karia, 40

Hanumath Kari Phones & Addresses

  • 1064 Hertford Dr, Hatfield, PA 19440 (215) 368-5316
  • Lansdale, PA
  • East Syracuse, NY
  • 1064 Hertford Dr, Hatfield, PA 19440 (215) 740-2524

Work

Position: Sales Occupations

Education

Degree: Associate degree or higher

Emails

h***[email protected]

Publications

Us Patents

Dihydropyrimidines And Uses Thereof

View page
US Patent:
6680323, Jan 20, 2004
Filed:
Jun 4, 2001
Appl. No.:
09/873746
Inventors:
Donghui Cui - Newtown PA
Margaret R. Davis - Redmond WA
Michael Dunn - Cambridge MA
Ben E. Evans - Lansdale PA
Hanumath P. Kari - Hatfield PA
Bharat Lagu - Maywood NJ
Dhanapalan Nagarathnam - Bethany CT
Kamlesh P. Vyas - North Wales PA
Kanyin Zhang - San Diego CA
Assignee:
Synaptic Pharmaceutical Corporation - Paramus NJ
International Classification:
A61K 31513
US Classification:
514258, 514275, 544278, 544316
Abstract:
This invention is directed to dihydropyrimidines which are selective antagonists for human receptors. This invention is also related to uses of these compounds for relaxing lower urinary tract tissue, treating benign prostatic hyperplasia and for the treatment of any disease where the antagonism of the receptor may be useful. The invention further provides a pharmaceutical composition comprising a therapeutically effective amount of the above-defined compounds and a pharmaceutically acceptable carrier.

Dihydropyrimidines And Uses Thereof

View page
US Patent:
20040138242, Jul 15, 2004
Filed:
Nov 6, 2003
Appl. No.:
10/702579
Inventors:
Donghui Cui - Newtown PA, US
Margaret Davis - Redmond WA, US
Michael Dunn - Cambridge MA, US
Ben Evans - Lansdale PA, US
Hanumath Kari - Hatfield PA, US
Bharat Lagu - Maywood NJ, US
Dhanapalan Nagarathnam - Bethany CT, US
Kamlesh Vyas - North Wales PA, US
Kanyin Zhang - San Diego CA, US
International Classification:
A61K031/513
C07D239/02
US Classification:
514/269000, 544/318000
Abstract:
This invention is directed to dihydropyrimidines which are selective antagonists for human receptors. This invention is also related to uses of these compounds for relaxing lower urinary tract tissue, treating benign prostatic hyperplasia and for the treatment of any disease where the antagonism of the receptor may be useful. The invention further provides a pharmaceutical composition comprising a therapeutically effective amount of the above-defined compounds and a pharmaceutically acceptable carrier.

Hmg-Coa Reductase Inhibitors

View page
US Patent:
47820845, Nov 1, 1988
Filed:
Jun 29, 1987
Appl. No.:
7/067503
Inventors:
Kamlesh P. Vyas - Harleysville PA
Hanumath P. Kari - Hatfield PA
Assignee:
Merck & Co., Inc. - Rahway NJ
International Classification:
A61K 31365
C07D30930
US Classification:
514460
Abstract:
Novel 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors which are useful as antihypercholesterolemic agents and are represented by the following general structural formulae (I) or (II): ##STR1## and pharmaceutically acceptable salts thereof the compounds of the formula (II) in which R. sup. 1 is hydrogen are disclosed.

Novel Hmg-Coa Reductase Inhibitors

View page
US Patent:
48853143, Dec 5, 1989
Filed:
Sep 1, 1988
Appl. No.:
7/239238
Inventors:
Kamlesh P. Vyas - Harleysville PA
Hanumath P. Kari - Hatfield PA
Assignee:
Merck & Co., Inc. - Rahway NJ
International Classification:
A61K 3119
US Classification:
514630
Abstract:
Novel 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors which are useful as antihypercholesterolemic agents and are represented by the following general structural formulae (I) or (II): ##STR1## and pharmaceutically acceptable salts thereof the compounds of the formula (II) in which R. sup. 1 is hydrogen are disclosed.

Dihydropyrimidines And Uses Thereof

View page
US Patent:
62745859, Aug 14, 2001
Filed:
Dec 23, 1999
Appl. No.:
9/470691
Inventors:
Donghui Cui - Newtown PA
Margaret R. Davis - Redmond WA
Michael Dunn - Cambridge MA
Ben E. Evans - Lansdale PA
Hanumath P. Kari - Hatfield PA
Bharat Lagu - Maywood NJ
Dhanapalan Nagarathnam - Bethany CT
Kamlesh P. Vyas - North Wales PA
Kanyin Zhang - San Diego CA
Assignee:
Synaptic Pharmaceutical Corporation - Paramus NJ
International Classification:
A61K 31513
A61K 31519
C07D23920
C07D491048
US Classification:
514258
Abstract:
This invention is directed to dihydropyrimidines which are selective antagonists for human. alpha. sub. 1a receptors. This invention is also related to uses of these compounds for relaxing lower urinary tract tissue, treating benign prostatic hyperplasia and for the treatment of any disease where the antagonism of the. alpha. sub. 1a receptor may be useful. The invention further provides a pharmaceutical composition comprising a therapeutically effective amount of the above-defined compounds and a pharmaceutically acceptable carrier.
Control profile
Hanumath G Kari from Hatfield, PA Get Report